Why Are They Silencing Kennedy? The Shocking Truth Behind the White House’s Bold Move!

Federal vaccine policy is navigating turbulent waters as Health and Human Services Secretary Robert F. Kennedy faces increasing scrutiny from lawmakers. Kennedy’s visit to Capitol Hill last September marked a significant shift in the administration's approach to vaccines, notably with the roll back of longstanding immunization guidance by members he selected for the Centers for Disease Control and Prevention's (CDC) vaccine advisory committee. This culminated in a unilateral overhaul of the childhood vaccine schedule in January.

However, during his testimony before three House committees last Thursday and Friday, Kennedy largely sidestepped discussions about vaccines, opting instead to highlight policies on nutrition and the administration's messaging regarding health care fraud and affordability. This reticence aligns with recent reports suggesting the White House has effectively pressed the pause button on Kennedy's anti-vaccine agenda.

As Kennedy faced lawmakers, the White House simultaneously announced new appointments within HHS, including a nominee for CDC director, a position that has remained vacant since Kennedy orchestrated the ousting of former Director Susan Monarez last summer. The new nominees are not aligned with Kennedy and lack reputations as vaccine skeptics, indicating a tightening of control over Kennedy, who leads the Medical and Health Advancement Agency (MAHA).

Kennedy will appear again this week before Senate panels that include Republicans who have previously scrutinized him. Six months ago, he was defiant in similar hearings, despite breaking pledges related to vaccine policy made during his confirmation. That period may have represented the height of Kennedy's influence within the administration, a stark contrast to his current precarious standing.

During his recent appearances, Kennedy defended the HHS portion of the president's fiscal year 2027 budget request. Rather than laying out a coherent strategy for appropriators, the budget appeared more as a platform for the administration to celebrate its successes. Kennedy echoed these themes in his written testimony, focusing on efforts to combat fraud, promote affordability, and prevent disease. He notably emphasized nutrition and dietary guidelines, arguing, “Preventing disease costs less and delivers better outcomes than treating it.”

Yet, Kennedy’s demeanor suggested a lack of enthusiasm for the budget, particularly regarding significant cuts to HHS programs. When questioned by the House Ways and Means Committee about these cuts, Kennedy candidly expressed, “I’m not happy about the cuts.” Similarly, Democratic lawmakers inquired about the reductions to the Substance Abuse and Mental Health Services Administration (SAMHSA), to which Kennedy could only confirm the cuts, stating, “I think that’s the proposal.”

Interestingly, no Republican committee members raised questions about Kennedy's vaccine policies or the administration's handling of the most significant measles outbreaks in over 30 years. Republican Rep. Jodey Arrington, whose district includes the epicenter of last year's outbreaks, praised Kennedy, calling him “a breath of fresh air,” and suggesting that he genuinely aims to improve public health.

However, Kennedy did not entirely evade vaccine-related topics. When queried about the CDC's guidance on the hepatitis B vaccine—an option for newborns until late last year when the advisory committee shifted to advising consultations with doctors—Kennedy reiterated his typical anti-vaccine stance: “Hepatitis B vaccine was not safety tested. We don’t know what the risk profile is.” This claim contradicts extensive studies over the last four decades that have shown the vaccine to be safe and effective.

While most Democrats used their time to criticize Kennedy's record, some brought up last year's measles outbreak. Democratic Rep. Linda Sánchez asked Kennedy if the unvaccinated children who died in Texas could have been saved by vaccination. Kennedy acknowledged, “It’s possible, certainly.” Yet, during the outbreak, he frequently amplified false claims about adverse vaccine effects and promoted unproven treatments. He once stated, “[The measles vaccine] does cause deaths every year,” a claim that lacks scientific backing.

Sánchez attributed the outbreaks directly to Kennedy’s anti-vaccine policies and the insufficient promotion of vaccinations by HHS and the CDC. Kennedy countered that many cases were among individuals who opted out of vaccinations before he took office, further blaming the Biden administration’s COVID-19 policies for declining vaccination rates. While some current cases stem from prior vaccine hesitancy, it is vital to note that Kennedy has been a prominent anti-vaccine activist during those times. Polling indicates that trust in vaccines has diminished under his leadership, and preliminary data from states like Michigan show a drop in young children completing routine immunizations, including the measles series.

Tensions rose during the hearings when lawmakers pressed Kennedy about the administration's rollbacks of MAHA priorities, such as the president’s executive order on glyphosate production. Kennedy expressed reservations about the order, stating, “I had grave reservations about the president’s executive order,” and confirmed to Democratic Rep. Mark Pocan that he still believes glyphosate is carcinogenic. The secretary's frustration escalated when Democratic Rep. Josh Harder inquired about the easing of mercury emissions limits on power plants, a change Kennedy claimed he was unfamiliar with, insisting it fell under the purview of the Environmental Protection Agency.

Overall, Kennedy's testimony mirrored his earlier confirmation hearings, where he downplayed his vaccine views to secure support from Republican senators. Now, however, he faces a White House that has grown wary of vaccine skepticism and is pushing for public health leadership free from anti-vaccine controversies.

A New CDC Nominee

On Thursday, President Trump announced Dr. Erica Schwartz as his nominee for CDC director. Schwartz, who served as deputy surgeon general during Trump’s first term, played a critical role in leading the administration’s COVID-19 response. Additionally, Dr. Jennifer Shuford, Texas’s state health commissioner known for promoting vaccinations during the measles outbreak, was named as the CDC’s deputy director and chief medical officer.

Filling vacancies at the CDC has proven challenging, with concerns about finding candidates who support vaccines while also aligning with Kennedy's controversial views. Jerome Adams, surgeon general during Trump’s first term, commented on this difficulty, stating, “It’s proving impossible to find folks who are appropriately supportive of vaccines but who also pass the RFK litmus test.” Schwartz and Shuford bring traditional public health backgrounds, indicating a potential shift away from Kennedy's influence in key health roles. Aaron Siri, an anti-vaccine lawyer and Kennedy ally, criticized Schwartz’s selection, calling it a “disaster.”

Adams praised Schwartz, asserting she possesses the “expertise, credibility, and integrity to lead the CDC effectively.” If confirmed, the pressing question will be whether the White House's efforts to control Kennedy will extend to the behind-the-scenes interactions on vaccine policy that he has managed over the past year. The administration appears to have established a strategy to stabilize HHS without dismissing Kennedy, allowing him to maintain a foothold while bringing in personnel focused on bolstering vaccine confidence.